17 alpha-hydroxyprogesterone caproate has been researched along with Precancerous Conditions in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, D; Zhu, RL | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Precancerous Conditions
| Article | Year |
|---|---|
[Changes in reproductive hormones levels in the treatment of endometrial precancerous lesion with hydroxyprogesterone caproate].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents; Delayed-Action Preparations; Endometrial Neoplasms; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Precancerous Conditions; Progesterone Congeners | 1994 |